Elite controllers as a model of functional cure

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Opinion in HIV and AIDS

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/COH.0b013e328345a328PMID 21460722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

  2011cited by this paper
• Reduced Replication Capacity of NL4-3 Recombinant Viruses Encoding Reverse Transcriptase–Integrase Sequences From HIV-1 Elite Controllers

  2011cited by this paper
• Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine

  2011cited by this paper
• Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control

  2010cited by this paper
• HIV Controller CD4+ T Cells Respond to Minimal Amounts of Gag Antigen Due to High TCR Avidity

  2010cited by this paper
• Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers

  2010cited by this paper
• The impact of CCL3L1 copy number in an HIV-1-infected white population

  2010cited by this paper
• Unstimulated Primary CD4+ T Cells from HIV-1-Positive Elite Suppressors Are Fully Susceptible to HIV-1 Entry and Productive Infection

  2010cited by this paper
• The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

  2010cited by this paper
• Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

  2010cited by this paper
• Control of HIV-1 replication in elite suppressors.

  2010cited by this paper
• HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals

  2010cited by this paper
• CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.

  2010cited by this paper
• HIV Controllers with HLA-DRB1*13 and HLA-DQB1*06 Alleles Have Strong, Polyfunctional Mucosal CD4+ T-Cell Responses

  2010cited by this paper
• Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus

  2010cited by this paper
• Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?

  2010cited by this paper
• HIV-1 Continues To Replicate and Evolve in Patients with Natural Control of HIV Infection

  2010cited by this paper
• Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.

  2010cited by this paper
• Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.

  2009cited by this paper
• The Challenge of Finding a Cure for HIV Infection

  2009cited by this paper
• Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

  2009cited by this paper
• Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

  2009cited by this paper
• HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

  2009cited by this paper
• Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.

  2009cited by this paper
• Elite Suppressor–Derived HIV-1 Envelope Glycoproteins Exhibit Reduced Entry Efficiency and Kinetics

  2009cited by this paper
• Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity.

  2009cited by this paper
• Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

  2009cited by this paper
• Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses1

  2009cited by this paper
• Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

  2009cited by this paper
• HLA Class I Subtype-Dependent Expansion of KIR3DS1+ and KIR3DL1+ NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection

  2009cited by this paper
• Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV

  2009cited by this paper
• Early Control of HIV-1 Infection in Long-Term Nonprogressors Followed Since Diagnosis in the ANRS SEROCO/HEMOCO Cohort

  2009cited by this paper
• T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors.

  2009cited by this paper
• A step ahead on the HIV collaboratory.

  2009cited by this paper
• Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.

  2008cited by this paper
• Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

  2008cited by this paper
• Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy

  2008cited by this paper
• Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid Changes

  2008cited by this paper
• HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors

  2008cited by this paper
• Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.

  2008cited by this paper
• HIV rebounds from latently infected cells, rather than from continuing low-level replication

  2008cited by this paper
• Transmission of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor

  2008cited by this paper
• Frequency and Phenotype of Human Immunodeficiency Virus Envelope-Specific B Cells from Patients with Broadly Cross-Neutralizing Antibodies

  2008cited by this paper
• Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.

  2008cited by this paper
• Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study

  2008cited by this paper
• Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

  2007cited by this paper
• Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.

  2007cited by this paper
• Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

  2007cited by this paper
• HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

  2007cited by this paper
• Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

  2007cited by this paper
• A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

  2007cited by this paper
• Viral Replication Capacity as a Correlate of HLA B57/B5801-Associated Nonprogressive HIV-1 Infection1

  2007cited by this paper
• Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutations

  2006cited by this paper
• Neutralizing Antibodies Do Not Mediate Suppression of Human Immunodeficiency Virus Type 1 in Elite Suppressors or Selection of Plasma Virus Variants in Patients on Highly Active Antiretroviral Therapy

  2006cited by this paper
• CD4+ count-guided interruption of antiretroviral treatment.

  2006cited by this paper
• Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity

  2006cited by this paper
• Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors

  2006cited by this paper
• Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection

  2006cited by this paper
• Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.

  2005cited by this paper
• Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression.

  2005cited by this paper
• HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

  2005cited by this paper
• First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection.

  2003cited by this paper
• HIV Type 1-Specific IgG2 Antibodies: Markers of Helper T Cell Type 1 Response and Prognostic Marker of Long-Term Nonprogression

  2001cited by this paper
• Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection

  2000cited by this paper
• HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

  2000cited by this paper
• Status of long‐term asymptomatic HIV‐1 infection correlates with viral load but not with virus replication properties and cell tropism

  1999cited by this paper
• HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

  1999cited by this paper
• Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infection.

  1999cited by this paper
• Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals.

  1999cited by this paper
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

  1997cited by this paper
• Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection

  1996cited by this paper
• Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

  1995cited by this paper
• Serveur Académique Lausannois SERVAL serval.unil.ch

  year unknowncited by this paper

• Learning from nature: HIV elite controllers as blueprints for a functional cure

  2025cites this paper
• Long-Term Elite Controllers of HIV-1 Infection Exhibit a Deep Perturbation of Monocyte Homeostasis

  2025cites this paper
• Association between baseline HIV-1 DNA levels and clinical outcomes in people living with HIV: a meta-analysis of cohort studies

  2025cites this paper
• Functional cure of HIV-1 infection in an exceptional elite controller: a case report.

  2025cites this paper
• Survival Analysis and Immune Differences of HIV Long-Term Non-progressors in Xinjiang China: A 12-Year Prospective Cohort Observation

  2024cites this paper
• T Cell Homeostasis Disturbances in a Cohort of Long-Term Elite Controllers of HIV Infection

  2024cites this paper
• A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection

  2024cites this paper
• NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control

  2024cites this paper
• Exceptional, naturally occurring HIV-1 control: Insight into a functional cure

  2024cites this paper
• Bibliometric and visualized analysis of elite controllers based on CiteSpace: landscapes, hotspots, and frontiers

  2023cites this paper
• Complex Dynamics for an Immunosuppressive Infection Model with Virus Stimulation Delay and Nonlinear Immune Expansion

  2023cites this paper
• HIV RNA/DNA Levels at Diagnosis Can Predict Immune Reconstitution: A Longitudinal Analysis

  2023cites this paper
• A metagenome-wide association study of HIV disease progression in HIV controllers

  2023cites this paper
• Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes

  2022cites this paper
• Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control

  2022cites this paper
• TILDA: Tat/Rev Induced Limiting Dilution Assay.

  2022cites this paper
• Role of CXCR5+ CD8+ T cells in human immunodeficiency virus-1 infection

  2022cites this paper
• High frequency of CD8 escape mutations in elite controllers as new obstacle for HIV cure

  2022cites this paper
• Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression

  2022cites this paper
• Portadores do vírus da imunodeficiência humana não progressores a longo prazo

  2021cites this paper
• Immunogenetic determinants of heterosexual HIV-1 transmission: Key findings and lessons from two distinct African cohorts

  2021cites this paper
• Distinct effects of treatment with two different interferon-alpha subtypes on HIV-1-associated T-cell activation and dysfunction in humanized mice

  2021cites this paper
• Inducible HIV-1 Reservoir Quantification: Clinical Relevance, Applications and Advancements of TILDA

  2021cites this paper
• Off the beaten path: Novel mRNA-nanoformulations for therapeutic vaccination against HIV.

  2020cites this paper
• Re-examining the HIV ‘functional cure’ oxymoron: Time for precise terminology?

  2020cites this paper
• Elite controllers: A heterogeneous group of HIV-infected patients

  2020cites this paper
• Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure

  2020cites this paper
• Persistent HIV‐controllers are more prone to spontaneously clear HCV: a retrospective cohort study

  2020cites this paper
• The importance of advanced cytometry in defining new immune cell types and functions relevant for the immunopathogenesis of HIV infection.

  2020cites this paper
• A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8+ T Cell Clonotypes Against Autologous HIV-1 Epitope Variants

  2020influential citation
• Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?

  2020cites this paper
• What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study

  2019cites this paper
• The Antibodiome—Mapping the Humoral Immune Response to HIV

  2019cites this paper
• HIV long-term non-progressors elite controllers: an interplay between host, immune and viral factors

  2019cites this paper
• HIV-2 as a model to identify a functional HIV cure

  2019cites this paper
• Dynamics in HIV‐DNA levels over time in HIV controllers

  2019cites this paper
• Elevated Expression of miR-19b Enhances CD8+ T Cell Function by Targeting PTEN in HIV Infected Long Term Non-progressors With Sustained Viral Suppression

  2019cites this paper
• What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study.

  2019cites this paper
• Elite controllers and lessons learned for HIV-1 cure.

  2019cites this paper
• Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors

  2019cites this paper
• Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers

  2018cites this paper
• Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients

  2018cites this paper
• The B-Cell Follicle in HIV Infection: Barrier to a Cure

  2018cites this paper
• Potential Application of MicroRNA Profiling to the Diagnosis and Prognosis of HIV-1 Infection

  2018cites this paper
• Plasmatic Levels of IL-18, IP-10, and Activated CD8+ T Cells Are Potential Biomarkers to Identify HIV-1 Elite Controllers With a True Functional Cure Profile

  2018cites this paper
• Considerations for the clinical management of elite controllers

  2018cites this paper
• Multidisciplinary analysis of HIV-1 elite controllers

  2018cites this paper
• What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM

  2017cites this paper
• Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART

  2017cites this paper
• CD8+ T cell epitope-enriched HIV-1-Gag antigens with preserved structure and function

  2017cites this paper
• Characterization of regulatory T cells and Th17 cells as reservoir of HIV-1 in chronic infection

  2017cites this paper
• An analysis of functional curability on HIV infection models with Michaelis-Menten-type immune response and its generalization

  2017cites this paper
• On the way to find a cure: Purging latent HIV‐1 reservoirs

  2017cites this paper
• Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes

  2017cites this paper
• Justification for the inclusion of Gag in HIV vaccine candidates

  2016cites this paper
• A NECESSARY CONDITON ON THE FUNCTIONAL CURABILITY OF HIV INFECTION

  2016cites this paper
• Balance between activation and regulation of HIV-specific CD8+ T-cell response after modified vaccinia Ankara B therapeutic vaccination

  2016cites this paper
• Molecular Mechanisms Controlling HIV Transcription and Latency – Implications for Therapeutic Viral Reactivation

  2016cites this paper
• Etude de l'interaction entre la protéine humaine Importin beta et la protéine du VIH-1 Rev

  2015cites this paper
• Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs

  2015cites this paper
• Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?

  2015cites this paper
• Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

  2015cites this paper
• Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs

  2015cites this paper
• Response to a Letter to the Editor by Joachim Denner on HIV infection en route to endogenization: two cases.

  2015cites this paper
• Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection

  2015cites this paper
• The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers

  2015cites this paper
• Quantification of viral DNA during HIV-1 infection: A review of relevant clinical uses and laboratory methods.

  2015cites this paper
• Gene therapy for HIV infection

  2015cites this paper
• Toward a cure for HIV—Seeking effective therapeutic vaccine strategies

  2015cites this paper
• The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon Infection.

  2015cites this paper
• HIV Infection, Immune-Based Interventions for

  2015cites this paper
• Antiretroviral therapy in the elite controller: justified or premature?

  2015cites this paper
• Systems integration of innate and adaptive immunity.

  2015cites this paper
• Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers

  2014cites this paper
• Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients

  2014cites this paper
• HIV Vaccine Development: Tools and Knowledge

  2014cites this paper
• HIV infection en route to endogenization: two cases

  2014cites this paper
• The interplay between the X-DING-CD4, IFN-α and IL-8 gene activity in quiescent and mitogen- or HIV-1-exposed PBMCs from HIV-1 elite controllers, AIDS progressors and HIV-negative controls

  2014cites this paper
• A cure for HIV: is it in sight?

  2014cites this paper
• APOBEC3-mediated hypermutation of retroviruses:A defensive tool of the innate immune system

  2014cites this paper
• Highlights on HIV eradication in 2013.

  2014cites this paper
• Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers

  2014cites this paper
• Vaccines & Vaccine Technologies

  2014cites this paper
• The FcγR of humans and non-human primates and their interaction with IgG: implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies.

  2014cites this paper
• Increased expression of SAMHD1 in a subset of HIV-1 elite controllers.

  2014cites this paper
• Systems-level analysis of innate immunity.

  2014cites this paper
• An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration

  2014cites this paper
• What is the significance of posttreatment control of HIV infection vis-à-vis functional cure?

  2014cites this paper
• A Correlate of HIV-1 Control Consisting of Both Innate and Adaptive Immune Parameters Best Predicts Viral Load by Multivariable Analysis in HIV-1 Infected Viremic Controllers and Chronically-Infected Non-Controllers

  2014cites this paper
• OPINION Immune control of HIV-1 reservoirs

  2013cites this paper
• Avances en el desarrollo de una estrategia efectiva para la vacuna contra el virus de la inmunodeficiencia humana

  2013cites this paper
• University of Groningen Distinct Tryptophan Catabolism and Th 17 / Treg Balance in HIV Progressors and Elite

  2013cites this paper
• Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease

  2013cites this paper
• How to best measure HIV reservoirs?

  2013cites this paper
• Attacking the HIV Reservoir from the Immune and Viral Perspective

  2013cites this paper
• Immune interventions in HIV infection

  2013influential citation
• Is cure of HIV infection in sight?

  2013cites this paper
• Immune control of HIV-1 reservoirs

  2013cites this paper
• HIV-1 Trans Infection of CD4+ T Cells by Professional Antigen Presenting Cells

  2013cites this paper
• Dissecting the Dynamics of HIV-1 Protein Sequence Diversity

  2013cites this paper